Profound Medical (TSE:PRN) Stock Price Down 9.5%

Shares of Profound Medical Corp. (TSE:PRN) traded down 9.5% during mid-day trading on Friday . The company traded as low as C$11.07 and last traded at C$11.07. 4,881 shares traded hands during mid-day trading, a decline of 8% from the average session volume of 5,295 shares. The stock had previously closed at C$12.23.

Profound Medical Price Performance

The business has a fifty day moving average of C$10.78 and a 200-day moving average of C$11.35. The company has a debt-to-equity ratio of 15.78, a quick ratio of 14.98 and a current ratio of 5.41. The firm has a market capitalization of C$270.44 million, a P/E ratio of -6.29 and a beta of 1.27.

Profound Medical (TSE:PRN) last released its quarterly earnings results on Thursday, May 9th. The company reported C($0.35) earnings per share (EPS) for the quarter, topping the consensus estimate of C($0.41) by C$0.06. The business had revenue of C$2.58 million during the quarter, compared to the consensus estimate of C$3.24 million. On average, sell-side analysts forecast that Profound Medical Corp. will post -1.9000001 EPS for the current fiscal year.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.